quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:03:24·168d
SECFiling
Maravai LifeSciences Holdings Inc. logo

Maravai LifeSciences Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

MRVI· Maravai LifeSciences Holdings Inc.
Health Care
Original source

Companies

  • MRVI
    Maravai LifeSciences Holdings Inc.
    Health Care

Recent analyst ratings

  • Feb 26UpdateRobert W. Baird$3.00
  • Dec 19UpdateGuggenheim-
  • Dec 5UpdateGoldman$4.25
  • Nov 14UpdateWolfe Research-
  • Nov 8UpdateWilliam Blair-
  • Aug 28UpdateWells Fargo$10.00

Related

  • PR3d
    Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
  • INSIDER37d
    Officer Dolan Christine covered exercise/tax liability with 28,661 shares, decreasing direct ownership by 6% to 420,312 units (SEC Form 4)
  • INSIDER37d
    General Counsel Oreshack Kurt covered exercise/tax liability with 39,976 shares, decreasing direct ownership by 9% to 384,991 units (SEC Form 4)
  • SEC56d
    SEC Form 10-K filed by Maravai LifeSciences Holdings Inc.
  • SEC57d
    Maravai LifeSciences Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR57d
    Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
  • SEC65d
    Amendment: SEC Form SCHEDULE 13G/A filed by Maravai LifeSciences Holdings Inc.
  • SEC69d
    Amendment: SEC Form SCHEDULE 13G/A filed by Maravai LifeSciences Holdings Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022